Dracunculiasis - Revision history

Rossdonaldson1: /* Background */

2020-12-12T12:32:07Z

Background

← Older revision		Revision as of 12:32, 12 December 2020
Line 1:		Line 1:
	==Background==		==Background==
	[[		[[File:Drac life cycle.png\|thumb\|Life cycle of ''Dracunculus medinensi''.]]
	File:Drac life cycle.png\|thumb\|Life cycle of ''Dracunculus medinensi''.]]
	*Also known as Guinea Worm disease		*Also known as Guinea Worm disease
	*Caused by ''Dracunculus medinensis'' - infection due to drinking contaminated water		*Caused by ''Dracunculus medinensis'' - infection due to drinking contaminated water

2020-12-12T12:31:57Z

Background

← Older revision		Revision as of 12:31, 12 December 2020
Line 1:		Line 1:
	==Background==		==Background==
			[[
			File:Drac life cycle.png\|thumb\|Life cycle of ''Dracunculus medinensi''.]]
	*Also known as Guinea Worm disease		*Also known as Guinea Worm disease
	*Caused by ''Dracunculus medinensis'' - infection due to drinking contaminated water		*Caused by ''Dracunculus medinensis'' - infection due to drinking contaminated water

2020-12-12T12:31:05Z

Clinical Features

← Older revision		Revision as of 12:31, 12 December 2020
Line 8:		Line 8:

	==Clinical Features==		==Clinical Features==
			[[File:Dracunculus medinensis.jpg\|thumb\|Using a matchstick to wind up and remove a guinea worm from the leg of a human.]]
	*Adult worm migrates through subcutaneous tissues of the leg and erodes through skin, approximately 1 year after infection<ref name="Hopkins">Hopkins DR, Ruiz-Tiben E, Eberhard ML, Roy SL; Centers for Disease Control and Prevention (CDC). Progress toward global eradication of dracunculiasis--January 2013-June 2014. MMWR Morb Mortal Wkly Rep. 2014 Nov 21;63(46):1050-4.</ref>		*Adult worm migrates through subcutaneous tissues of the leg and erodes through skin, approximately 1 year after infection<ref name="Hopkins">Hopkins DR, Ruiz-Tiben E, Eberhard ML, Roy SL; Centers for Disease Control and Prevention (CDC). Progress toward global eradication of dracunculiasis--January 2013-June 2014. MMWR Morb Mortal Wkly Rep. 2014 Nov 21;63(46):1050-4.</ref>
	*Symptoms prior to eruption include: [[rash]], intense [[pruritus]], [[nausea/vomiting]], [[dyspnea]], and [[diarrhea]]		*Symptoms prior to eruption include: [[rash]], intense [[pruritus]], [[nausea/vomiting]], [[dyspnea]], and [[diarrhea]]

2020-12-12T12:24:09Z

← Older revision		Revision as of 12:24, 12 December 2020
Line 4:		Line 4:
	*Generally limited to central Africa		*Generally limited to central Africa
	**Effort underway to eradicate disease in endemic countries<ref name="Hopkins" />		**Effort underway to eradicate disease in endemic countries<ref name="Hopkins" />

			{{Helminth Types}}

	==Clinical Features==		==Clinical Features==
Line 11:		Line 13:
	==Differential Diagnosis==		==Differential Diagnosis==
	{{Travel Skin Conditions DDX}}		{{Travel Skin Conditions DDX}}
	~~{{Helminth Types}}~~

	==Evaluation==		==Evaluation==

2020-12-12T12:23:32Z

Differential Diagnosis

2016-10-05T05:14:37Z

Clinical Features

← Older revision		Revision as of 05:14, 5 October 2016
Line 7:		Line 7:
	==Clinical Features==		==Clinical Features==
	*Adult worm migrates through subcutaneous tissues of the leg and erodes through skin, approximately 1 year after infection<ref name="Hopkins">Hopkins DR, Ruiz-Tiben E, Eberhard ML, Roy SL; Centers for Disease Control and Prevention (CDC). Progress toward global eradication of dracunculiasis--January 2013-June 2014. MMWR Morb Mortal Wkly Rep. 2014 Nov 21;63(46):1050-4.</ref>		*Adult worm migrates through subcutaneous tissues of the leg and erodes through skin, approximately 1 year after infection<ref name="Hopkins">Hopkins DR, Ruiz-Tiben E, Eberhard ML, Roy SL; Centers for Disease Control and Prevention (CDC). Progress toward global eradication of dracunculiasis--January 2013-June 2014. MMWR Morb Mortal Wkly Rep. 2014 Nov 21;63(46):1050-4.</ref>
	*Symptoms prior to eruption include: rash, intense pruritus, nausea, vomiting, dyspnea, and diarrhea		*Symptoms prior to eruption include: [[rash]], intense [[pruritus]], [[nausea/vomiting]], [[dyspnea]], and [[diarrhea]]

	==Differential Diagnosis==		==Differential Diagnosis==

2016-08-01T18:47:41Z

Text replacement - "approx " to "approximately "

← Older revision		Revision as of 18:47, 1 August 2016
Line 6:		Line 6:

	==Clinical Features==		==Clinical Features==
	*Adult worm migrates through subcutaneous tissues of the leg and erodes through skin, ~~approx~~ 1 year after infection<ref name="Hopkins">Hopkins DR, Ruiz-Tiben E, Eberhard ML, Roy SL; Centers for Disease Control and Prevention (CDC). Progress toward global eradication of dracunculiasis--January 2013-June 2014. MMWR Morb Mortal Wkly Rep. 2014 Nov 21;63(46):1050-4.</ref>		*Adult worm migrates through subcutaneous tissues of the leg and erodes through skin, approximately 1 year after infection<ref name="Hopkins">Hopkins DR, Ruiz-Tiben E, Eberhard ML, Roy SL; Centers for Disease Control and Prevention (CDC). Progress toward global eradication of dracunculiasis--January 2013-June 2014. MMWR Morb Mortal Wkly Rep. 2014 Nov 21;63(46):1050-4.</ref>
	*Symptoms prior to eruption include: rash, intense pruritus, nausea, vomiting, dyspnea, and diarrhea		*Symptoms prior to eruption include: rash, intense pruritus, nausea, vomiting, dyspnea, and diarrhea

2016-07-23T11:48:41Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

2016-07-19T04:25:38Z

Text replacement - "0 mg" to "0mg"

← Older revision		Revision as of 04:25, 19 July 2016
Line 16:		Line 16:

	==Management==		==Management==
	*Metronidazole ~~750 mg~~ TID x 5-10 days '''OR''' thiabendazole 50-75mg/day divided BID x 3 days		*Metronidazole 750mg TID x 5-10 days '''OR''' thiabendazole 50-75mg/day divided BID x 3 days
	*Must also extract adult worm from skin		*Must also extract adult worm from skin
	*Patients with active skin lesions should avoid contact with potable water		*Patients with active skin lesions should avoid contact with potable water

2016-07-18T19:23:34Z

Text replacement - "5 mg" to "5mg"

← Older revision		Revision as of 19:23, 18 July 2016
Line 16:		Line 16:

	==Management==		==Management==
	*Metronidazole 750 mg TID x 5-10 days '''OR''' thiabendazole 50-~~75 mg~~/day divided BID x 3 days		*Metronidazole 750 mg TID x 5-10 days '''OR''' thiabendazole 50-75mg/day divided BID x 3 days
	*Must also extract adult worm from skin		*Must also extract adult worm from skin
	*Patients with active skin lesions should avoid contact with potable water		*Patients with active skin lesions should avoid contact with potable water